(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.38%) $966.30
(-0.36%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
13.17% SEK 0.110
Live Chart Being Loaded With Signals
Promore Pharma AB (publ), a biopharmaceutical company, develops peptide-based drug candidates in Sweden and internationally. Its product candidates include PXL01 that is in Phase IIa study for the prevention of post-surgical adhesions and scars, and for the prevention of dermal scars, as well as for tendon repair surgery in the hand; and LL-37, which is in Phase IIb clinical studies for treating patients with venous leg ulcers, stimulate the healing of chronic wounds, and for the treatment of diabetic foot ulcers...
Stats | |
---|---|
Volumen de hoy | 1.12M |
Volumen promedio | 2.06M |
Capitalización de mercado | 293.55M |
EPS | SEK-0.0643 ( 2023-09-30 ) |
Last Dividend | SEK0 ( N/A ) |
Next Dividend | SEK0 ( N/A ) |
P/E | -0.314 |
ATR14 | SEK5.16 (36.49%) |
Volumen Correlación
Promore Pharma AB (publ) Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Promore Pharma AB (publ) Correlación - Moneda/Commodity
Promore Pharma AB (publ) Finanzas
Annual | 2022 |
Ingresos: | SEK99 000.00 |
Beneficio Bruto: | SEK-15.85M (-16 005.05 %) |
EPS: | SEK-0.440 |
FY | 2022 |
Ingresos: | SEK99 000.00 |
Beneficio Bruto: | SEK-15.85M (-16 005.05 %) |
EPS: | SEK-0.440 |
FY | 2021 |
Ingresos: | SEK417 000 |
Beneficio Bruto: | SEK-14.90M (-3 571.94 %) |
EPS: | SEK-0.561 |
FY | 2020 |
Ingresos: | SEK3 000.00 |
Beneficio Bruto: | SEK-18.20M (-606 733.33 %) |
EPS: | SEK-0.796 |
Financial Reports:
No articles found.
Promore Pharma AB (publ)
Promore Pharma AB (publ), a biopharmaceutical company, develops peptide-based drug candidates in Sweden and internationally. Its product candidates include PXL01 that is in Phase IIa study for the prevention of post-surgical adhesions and scars, and for the prevention of dermal scars, as well as for tendon repair surgery in the hand; and LL-37, which is in Phase IIb clinical studies for treating patients with venous leg ulcers, stimulate the healing of chronic wounds, and for the treatment of diabetic foot ulcers. It entered into a cooperation agreement with Fidia Farmaceutici S.p.A. for the production of hyaluronic acid syringes. The company was formerly known as Lipopeptide AB and changed its name to Promore Pharma AB (publ) in January 2017. Promore Pharma AB (publ) was founded in 2002 and is headquartered in Solna, Sweden.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico